BackBioCardia - Warrants (26/07/2022) Overview

BioCardia - Warrants (26/07/2022) Other Current Assets

BioCardia - Warrants (26/07/2022)'s other current assets is $150K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$151000.00
27.75% YoYΔ $-58000.00 vs prior year quarter

Peer average / median

Loading

BioCardia - Warrants (26/07/2022) Other Current Assets History

Loading

BioCardia - Warrants (26/07/2022) vs. peers: Other Current Assets Comparison

Loading

BioCardia - Warrants (26/07/2022) Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioCardia - Warrants (26/07/2022) (BCDAW) FAQ

As of the most recent data (June 2026), BCDAW shows a other current assets of $150K. That compares with $210K in the prior-year period — down 27.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCDAW's other current assets is now $150K (was $210K) — a 27.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioCardia - Warrants (26/07/2022) is outperforming or lagging.

Tracking BCDAW's other current assets over time shows whether BioCardia - Warrants (26/07/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $150K That compares with $210K in the prior-year period — down 27.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has BioCardia - Warrants (26/07/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $150K) with ownership activity and broader fundamentals.

BioCardia - Warrants (26/07/2022)'s other current assets is $150K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.